Results 91 to 100 of about 2,946 (126)

[Electrotherapy and sensory re-education as a treatment for chemotherapy-induced neuropathy]. [PDF]

Rev Med Inst Mex Seguro Soc
Pérez-Gómez DC, Toro-Sashida MF, González-Ojeda A, Romero-Collazo EF, Gutiérrez-Casillas SB, Gómez-Sierra JP, Fuentes-Orozco C.   +6 more
europepmc   +1 more source

Fármaco vigilancia de los antineoplásicos, utilizados en la unidad hemato-oncológica pediátrica del Hospital Universitario “Dr. Ángel Larralde”. Valencia Estado Carabobo durante el primer semestre del año 2006

, 2011
El presente estudio tuvo como objetivo determinar las posibles Reacciones Adversas de los antineoplásicos, utilizados en la Unidad Hemato-Oncológica Pediátrica del Hospital Universitario “Dr. Ángel Larralde”.
Navarro, Yoleyda
core  

Root cause analysis of safety incidents in antineoplastic use in children. [PDF]

Rev Bras Enferm
Barreto EDG, Sandes VS, Nobre GC, Martins M, Ferman SE, Lima EC.   +5 more
europepmc   +1 more source

SARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context. [PDF]

Arch Bronconeumol, 2020
Isea de la Viña J, Ortega Granados AL, Alcázar-Navarrete B.   +2 more
europepmc   +1 more source

[Prevalence of hearing loss in a high-specialty medical unit]. [PDF]

Rev Med Inst Mex Seguro Soc
Baca-Sigler BG, Moreno-Palacios J, Waizel-Haiat S.   +2 more
europepmc   +1 more source

Financial impact of centralized purchasing of rituximab by the Brazilian Ministry of Health for lymphoma treatment, 2015-2022: an exploratory study. [PDF]

Epidemiol Serv Saude
Martins RR, Zara ALSA, Melo DO, Simone ALM.   +3 more
europepmc   +1 more source

Characterization of the safety notes of pharmaceutical products issued by two regulatory authorities from Latin America. [PDF]

Rev Peru Med Exp Salud Publica
Pérez-Salazar K, Yataco-Camarena M, Rodríguez-Tanta LY.   +2 more
europepmc   +1 more source

[Drug shortages in Family Medicine practice]. [PDF]

Aten Primaria
Esteban-Jiménez Ó, Hernández-Rodríguez MÁ.   +1 more
europepmc   +1 more source

Impact of the use of antibiotics on the clinical response to immune checkpoint inhibitors in patients with non-small cell lung cancer. [PDF]

Rev Esp Quimioter, 2022
Martinez-Mugica Barbosa C, Cercós Lletí AC, Pampín Sánchez R, Durán Román C, Terroba Alonso P, Fernández González B.   +5 more
europepmc   +1 more source

[Impact of the SARS-CoV-2 pandemic on the start of prescriptions]. [PDF]

J Healthc Qual Res, 2020
Mendizabal Olaizola A, Valverde Bilbao E.   +1 more
europepmc   +1 more source